Why Farbe Firma is the Top Manufacturer of Hydroxocobalamin (B12) Injection
- Maulik Sudani
- 7 hours ago
- 7 min read
Last Updated: May 30, 2026
TL;DR: Hydroxocobalamin (B12) Injection — a sterile parenteral solution of the natural vitamin B12 (cobalamin) analogue hydroxocobalamin, supplied most commonly as 1,000 mcg/mL (1 mg/mL) in 1 mL amber-glass ampoules — is the long-acting, tissue-retained injectable form of vitamin B12 used to treat and prevent vitamin B12 deficiency, pernicious anaemia, megaloblastic anaemia, and the neurological manifestations of cobalamin deficiency, and at high strength (2.5 g and 5 g vials) as an emergency intravenous antidote to cyanide poisoning. Because hydroxocobalamin binds plasma proteins and is retained in the body far longer than cyanocobalamin, a single intramuscular dose maintains therapeutic cover for weeks to months, allowing maintenance dosing as infrequently as once every two to three months. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Hydroxocobalamin (B12) Injection at our Gujarat, India facility and supplies it to hospital tenders, haematology and neurology services, primary-care programmes, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Vitamin B12 (cobalamin) analogue and haematinic — Hydroxocobalamin (B12) Injection is the long-acting, tissue-retained parenteral form of vitamin B12 for treating pernicious anaemia, dietary and malabsorptive B12 deficiency, megaloblastic anaemia and cobalamin-related neuropathy, with single-dose cover lasting weeks to months; at high strength it also serves as an emergency intravenous cyanide antidote.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified amber-glass ampoule filling lines, dedicated handling for a deep-red, intensely photosensitive and oxidation-sensitive cobalamin solution requiring amber glass, nitrogen overlay, light-protective processing and full container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets — including ministry-of-health hospital, haematology and primary-care tenders.
End-to-end CDMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready ampoule packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Hydroxocobalamin (B12) Injection Demands a Premium Manufacturer
Hydroxocobalamin (B12) Injection occupies a quietly essential place on the haematology and primary-care shelf. It is the injectable vitamin B12 of choice for patients who cannot absorb the vitamin from food — those with pernicious anaemia and an absent intrinsic factor, with prior gastric or ileal resection, with autoimmune or inflammatory malabsorption, or on long-term metformin or proton-pump-inhibitor therapy — and for strict vegans and the elderly whose dietary intake has failed. Clinicians prefer hydroxocobalamin over cyanocobalamin precisely because it is retained: bound to transcobalamin and stored in the liver, it leaves the circulation slowly, so an induction course followed by a single intramuscular injection every two to three months sustains normal haematopoiesis and protects the nervous system from the irreversible subacute combined degeneration that untreated B12 deficiency can cause. At 2.5 g and 5 g strengths the same molecule becomes a life-saving intravenous antidote for cyanide poisoning, chelating cyanide into renally excreted cyanocobalamin.
That clinical reality places real demands on the manufacturer. Hydroxocobalamin is a large, deeply red cobalt-centred corrinoid that is freely water soluble but exquisitely sensitive to light and to oxidation: ordinary daylight will photolyse it, and trace oxygen or metal ions will degrade the cobalamin ring over the shelf life of the product. The only practical way to deliver a stable 1,000 mcg/mL parenteral dose is as a sterile aqueous solution filled into amber-glass ampoules under an inert nitrogen overlay, with light-protective handling at every step from compounding to secondary packaging. Assay precision matters because the dose is measured in micrograms and the colour of the solution is itself a stability indicator. Choosing a Hydroxocobalamin Injection manufacturer that treats photostability, oxidative protection, micro-dose assay accuracy and container-closure integrity as core engineering disciplines is what protects long-interval B12 maintenance and emergency antidote supply at the bedside.
What Sets a World-Class Hydroxocobalamin Injection Manufacturer Apart
A world-class manufacturer of Hydroxocobalamin (B12) Injection invests in three areas that weaker suppliers underfund: rigorous photostability and oxidative protection across the full shelf life of an intensely light-sensitive cobalamin, microgram-level assay precision for a product dosed in thousands of micrograms per millilitre, and tender-ready dossier support for a product that moves overwhelmingly through hospital, haematology and ministry-of-health procurement. It starts with the active pharmaceutical ingredient — pharmacopoeial-grade hydroxocobalamin sourced from qualified, audited API manufacturers, with full impurity profiling, related-corrinoid control, water content and certificates of analysis cross-checked by the receiving laboratory before any material enters production.
Formulation, filling and packaging then have to protect the molecule end to end. The bulk solution is built at controlled pH with appropriate stabilisers and, where specified, sodium chloride for tonicity, sparged with nitrogen to displace dissolved oxygen, sterile-filtered through 0.22 µm membrane, and filled under ISO Class 5 air into amber-glass ampoules under a nitrogen headspace. Compounding and filling are performed under subdued, photolysis-safe lighting, and ampoules move straight into light-protective secondary cartons. In-process assay confirms the 1,000 mcg/mL label strength, container-closure integrity is verified on every batch, and the characteristic deep-red colour and clarity of the solution are checked as a direct, visible marker of cobalamin integrity. Stability is followed under ICH Q1A long-term and accelerated conditions and, critically, under ICH Q1B photostability protocols.
Quality Systems Behind Every Hydroxocobalamin (B12) Injection
Every Farbe Firma Hydroxocobalamin (B12) Injection batch is released only after a full stack of quality checks: HPLC assay against USP, BP, IP or EP reference standards, related-substances and cobalamin-degradation profiling, colour and clarity of the solution, pH and osmolarity, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, container-closure integrity, and fill-volume verification for the 1 mL ampoule at 1,000 mcg/mL. Certificates of analysis are issued with full traceability back to the API lot, the amber-glass primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, calibrated sterilisation and depyrogenation equipment, validated terminal sterilisation or validated aseptic filling with load mapping for the ampoule format, nitrogen-overlay and light-control procedures embedded in the master batch record, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — and the product is challenged against ICH Q1B photostability requirements that are uniquely important for a cobalamin solution.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Hydroxocobalamin Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across haematinic, vitamin, anaesthesia, anti-infective, obstetric, neonatal and supportive-care categories. For Hydroxocobalamin (B12) Injection specifically, we supply 1,000 mcg/mL solution in 1 mL amber-glass ampoules under WHO-GMP conditions, with country-specific strengths, ampoule and vial formats and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the photostability and oxidative-protection data package — ready to hand for registration.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination. When a buyer needs Hydroxocobalamin (B12) Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, light-protective artwork, production slot and shipment plan delivered as a single coordinated package, with one accountable point of contact throughout.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the amber-ampoule filling suite; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, photostability protection, nitrogen-overlay control, micro-dose assay validation, sterilisation, container-closure and stability choices in real detail. For a vitamin given as long-interval maintenance to patients who depend on it to protect their nervous system, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Hydroxocobalamin Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Hydroxocobalamin (B12) Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified amber-glass ampoule filling lines, nitrogen-overlay and light-control procedures, qualified water-for-injection systems, validated sterilisation cycles and continuous environmental monitoring.
Which strengths and pack sizes of Hydroxocobalamin (B12) Injection do you supply?
Our standard presentation is 1,000 mcg/mL (1 mg/mL) hydroxocobalamin solution in 1 mL amber-glass ampoules. Custom strengths, higher-strength vials, alternative fill volumes and country-specific pack configurations are available under contract manufacturing agreements.
Can Farbe Firma support country-specific registrations for Hydroxocobalamin (B12) Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, the photostability and oxidative-protection data, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries.
How does Farbe Firma protect the potency and photostability of Hydroxocobalamin (B12) Injection?
We compound and fill under subdued, photolysis-safe lighting with a nitrogen overlay to displace oxygen, fill into amber-glass ampoules, move product straight into light-protective secondary cartons, run HPLC assay and related-substances testing on every batch, verify the deep-red colour and clarity of the solution as a stability marker, and qualify each batch against ICH Q1A and ICH Q1B protocols.
What is the minimum order quantity for Hydroxocobalamin (B12) Injection contract manufacturing?
MOQs vary by strength, ampoule or vial format, label complexity and dossier requirements. For the 1,000 mcg/mL ampoule presentation we accommodate primary-care, hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments